Milind Deshpande - May 29, 2024 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
Director
Signature
/s/Satyavrat Shukla, Attorney-in-Fact for Milind Deshpande
Stock symbol
SPRO
Transactions as of
May 29, 2024
Transactions value $
$0
Form type
4
Date filed
5/30/2024, 04:29 PM
Previous filing
Oct 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRO Common Stock Award $0 +20K +38.87% $0.00 71.5K May 29, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on May 29, 2025, subject to the Reporting Person's continued service through the applicable vesting date.